Clinical Trials in Nashville

Showing 7641-7660 of 15,379 trials

Bevacizumab and Cetuximab in Combination With FOLFOX6 in Patients With Metastatic Colorectal Cancer

NCT00193219

This trial will evaluate the combination of modified infusional 5-fluorouracil/ leucovorin, oxaliplatin (FOLFOX6), bevacizumab, and cetuximab in patients with metastatic colorectal cancer. FOLFOX6 has proven to be a safe and effective regimen in first line treatment of advanced colorectal cancer. The role of epidermal growth factor (EGFR) inhibitors in an earlier treatment setting in combination with optimal chemotherapy regimens is an important emerging question.

Colon Cancer

SCRI Development Innovations, LLC36 participantsStarted Jul 2005

Evansville, Indiana, United States • Louisville, Kentucky, United States • Portland, Maine, United States +7 more locations

TERMINATEDPhase 2< 1 mile

Brodalumab (AMG 827) in Adults With Moderate to Severe Crohn's Disease

NCT01150890

The study will examine the safety and effectiveness of brodalumab for the treatment of moderate to severe Crohn's disease. Participants will randomly assigned to receive either brodalumab or placebo (a lookalike liquid that doesn't have any drug in it) and neither the doctor nor the patient will know what treatment is being given.

Crohn's Disease

Amgen130 participantsStarted Nov 2010

Birmingham, Alabama, United States • Dothan, Alabama, United States • Lowell, Arkansas, United States +47 more locations

Bevacizumab and Cetuximab in Combination With FOLFOX6 in Patients With Metastatic Colorectal Cancer

Brodalumab (AMG 827) in Adults With Moderate to Severe Crohn's Disease

Find Trials by Condition in Nashville

A Study of HTD1801 in Adults With Nonalcoholic Steatohepatitis (NASH) and Type 2 Diabetes Mellitus (T2DM)

Phase 4 IOP Signals Associated With ILUVIEN®

A Study of CNSA-001 in Women With Diabetic Gastroparesis

Study of Roxadustat (FG-4592) in Participants With End-Stage Renal Disease Receiving Maintenance Hemodialysis

Radiation Therapy, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Locally Advanced Squamous Cell Cancer of the Vulva

A Phase 3 Trial of the Safety, Tolerability and Efficacy of TransCon hGH Weekly Versus Daily hGH in Children With Growth Hormone Deficiency (GHD)

Evaluating the Safety and Pharmacokinetics of Maraviroc in HIV-1-Exposed Infants at Risk of Acquiring HIV-1 Infection

The RE-ENERGIZE Study: RandomizEd Trial of ENtERal Glutamine to minimIZE Thermal Injury

A Study Evaluating the Efficacy and Safety of AG-348 in Regularly Transfused Adult Participants With Pyruvate Kinase Deficiency (PKD)

Congenital Heart Initiative-Redefining Outcomes and Navigation to Adult Centered Care

Optimization for Regorafenib in HCC

Efficacy and Safety of Donepezil Hydrochloride in Preadolescent and Adolescent Children With Attention Impairment Following Cancer Treatment

A Study of Venetoclax in Combination With Cobimetinib and Venetoclax in Combination With Idasanutlin in Patients With Relapsed or Refractory Acute Myeloid Leukemia Who Are Not Eligible for Cytotoxic Therapy

FARE Peanut SLIT and Early Tolerance Induction

Strategies to Prevent Transcatheter Heart Valve Dysfunction in Low Risk Transcatheter Aortic Valve Replacement

Comparative Bioavailability of Risperidone.

A Study of Idasanutlin With Cytarabine Versus Cytarabine Plus Placebo in Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML)

EL CENTRO: Engaging Latinos in the Center of Cancer Treatment Options